Literature DB >> 1698558

Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms.

D M Anderson1, S D Lyman, A Baird, J M Wignall, J Eisenman, C Rauch, C J March, H S Boswell, S D Gimpel, D Cosman.   

Abstract

We have previously reported the identification of a novel mast cell growth factor (MGF) that was shown to be a ligand for c-kit and is encoded by a gene that maps near the steel locus on mouse chromosome 10. We now report the cloning of cDNAs encoding the MGF protein. The MGF protein encoded by this cDNA can be expressed in a biologically active form as either a membrane bound protein or as a soluble factor. The soluble protein promotes the proliferation of MGF-responsive cell lines and, in the presence of erythropoietin, stimulates the formation of macroscopic [corrected] erythroid and multilineage hematopoietic colonies.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1698558     DOI: 10.1016/0092-8674(90)90304-w

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  147 in total

1.  Differential expression and processing of two cell associated forms of the kit-ligand: KL-1 and KL-2.

Authors:  E J Huang; K H Nocka; J Buck; P Besmer
Journal:  Mol Biol Cell       Date:  1992-03       Impact factor: 4.138

2.  p21ras activation via hemopoietin receptors and c-kit requires tyrosine kinase activity but not tyrosine phosphorylation of p21ras GTPase-activating protein.

Authors:  V Duronio; M J Welham; S Abraham; P Dryden; J W Schrader
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

3.  SH2 domains of the p85 alpha subunit of phosphatidylinositol 3-kinase regulate binding to growth factor receptors.

Authors:  C J McGlade; C Ellis; M Reedijk; D Anderson; G Mbamalu; A D Reith; G Panayotou; P End; A Bernstein; A Kazlauskas
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

Review 4.  The extracellular regulation of growth factor action.

Authors:  R Flaumenhaft; D B Rifkin
Journal:  Mol Biol Cell       Date:  1992-10       Impact factor: 4.138

5.  Chymase cleavage of stem cell factor yields a bioactive, soluble product.

Authors:  B J Longley; L Tyrrell; Y Ma; D A Williams; R Halaban; K Langley; H S Lu; N M Schechter
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

6.  Temporary amniotic membrane patch for the treatment of primary pterygium: mechanisms of reducing the recurrence rate.

Authors:  Juan Ye; Koung Hoon Kook; Ke Yao
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-09-17       Impact factor: 3.117

7.  Interspecies molecular chimeras of kit help define the binding site of the stem cell factor.

Authors:  S Lev; J Blechman; S Nishikawa; D Givol; Y Yarden
Journal:  Mol Cell Biol       Date:  1993-04       Impact factor: 4.272

8.  Comparison of Human Hematopoietic Reconstitution in Different Strains of Immunodeficient Mice.

Authors:  Ashley I Beyer; Marcus O Muench
Journal:  Stem Cells Dev       Date:  2016-10-27       Impact factor: 3.272

9.  Phenotypic characterization of skin lesions in urticaria pigmentosa and mastocytomas.

Authors:  N Haas; K Hamann; J Grabbe; B Algermissen; B M Czarnetzki
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

10.  An allelic series of mutations in the kit ligand gene of mice. I. Identification of point mutations in seven ethylnitrosourea-induced Kitl(Steel) alleles.

Authors:  S Rajaraman; W S Davis; A Mahakali-Zama; H K Evans; L B Russell; M A Bedell
Journal:  Genetics       Date:  2002-09       Impact factor: 4.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.